StockData
Shoulder Innovations, Inc. logo

Shoulder Innovations, Inc. (SI) stock

SINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3049% above fair value
$20.31−0.34 (-1.65%)

Close on Nov 19, 2026Market cap $422.83MP/E –Yield –

Shoulder Innovations free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Shoulder Innovations's free cash flow for the twelve months ending Jun 30, 2026 was -$47.08M. For fiscal 2025 it was -$36.02M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$36.02M–
FY2024Dec 31, 2024-$18.16M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.55M–
Q1 FY2026Mar 31, 2026-$15.09M–
Q4 FY2025Dec 31, 2025-$11.07M–
Q3 FY2025Sep 30, 2025-$11.37M–
Q2 FY2025Jun 30, 2025-$6.27M–
Q1 FY2025Mar 31, 2025-$7.32M–
Q4 FY2024Dec 31, 2024-$4.32M–
Q3 FY2024Sep 30, 2024-$5.78M–

More Shoulder Innovations figures

See a number that looks wrong?